- Home
- VVPR vs COEP Comparison
VVPR vs COEP Comparison
Compare VVPR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VVPR | COEP |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2M | 100.4M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | VVPR | COEP |
|---|---|---|
| Price | $3.20 | $14.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 498.2K | 91.6K |
| Earning Date | 09-02-2023 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $61,000.00 | ★ $500,996.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 281.25 | N/A |
| 52 Week Low | $0.62 | $2.31 |
| 52 Week High | $8.88 | $21.41 |
Technical Indicators
Market Signals| Indicator | VVPR | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 41.33 |
| Support Level | $2.59 | $14.82 |
| Resistance Level | $3.20 | $16.60 |
| Average True Range (ATR) | 0.26 | 1.51 |
| MACD | 0.12 | -0.26 |
| Stochastic Oscillator | 91.38 | 9.62 |
Price Performance
Historical ComparisonAbout VVPR VivoPower International PLC
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.